Veracyte (VCYT) Non-Current Deffered Revenue (2012 - 2022)

Veracyte has disclosed Non-Current Deffered Revenue across 10 years of filings, most recently posting $278000.0 for Q1 2022.

• Non-Current Deffered Revenue for Q1 2022 came in at $278000.0, down 62.78% year-over-year; the trailing twelve-month figure through Mar 2022 was $278000.0 (down 62.78% YoY), and the FY2021 annual result was $343000.0, down 58.62% from the prior year.
• Non-Current Deffered Revenue came in at $278000.0 for Q1 2022 at Veracyte, down from $343000.0 in the prior quarter.
• In the past five years, Non-Current Deffered Revenue ranged from a high of $4.1 million in Q1 2018 to a low of $278000.0 in Q1 2022.
• The 4-year median for Non-Current Deffered Revenue is $788000.0 (2020), against an average of $1.9 million.
• Across the five-year window, Non-Current Deffered Revenue declined 6.36% in 2018 and sank 62.78% in 2022, its largest moves.
• Veracyte's Non-Current Deffered Revenue stood at $3.9 million in 2018, then slumped by 78.74% to $829000.0 in 2020, then slumped by 58.62% to $343000.0 in 2021, then dropped by 18.95% to $278000.0 in 2022.
• The last three Non-Current Deffered Revenue figures came in at $278000.0 (Q1 2022), $343000.0 (Q4 2021), and $552000.0 (Q3 2021), per Business Quant data.